177 related articles for article (PubMed ID: 36898366)
1. Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.
Forlenza CJ; Chadburn A; Giulino-Roth L
J Natl Compr Canc Netw; 2023 Mar; 21(3):323-330. PubMed ID: 36898366
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.
Giulino-Roth L; O'Donohue T; Chen Z; Bartlett NL; LaCasce A; Martin-Doyle W; Barth MJ; Davies K; Blum KA; Christian B; Casulo C; Smith SM; Godfrey J; Termuhlen A; Oberley MJ; Alexander S; Weitzman S; Appel B; Mizukawa B; Svoboda J; Afify Z; Pauly M; Dave H; Gardner R; Stephens DM; Zeitler WA; Forlenza C; Levine J; Williams ME; Sima JL; Bollard CM; Leonard JP
Br J Haematol; 2017 Dec; 179(5):739-747. PubMed ID: 29082519
[TBL] [Abstract][Full Text] [Related]
3. Dose-adjusted EPOCH-R is not superior to sequential R-CHOP/R-ICE as a frontline treatment for newly diagnosed primary mediastinal B-cell lymphoma: Results of a bi-center retrospective study.
Morgenstern Y; Aumann S; Goldschmidt N; Gatt ME; Nachmias B; Horowitz NA
Cancer Med; 2021 Dec; 10(24):8866-8875. PubMed ID: 34816617
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.
Zhou H; Xu-Monette ZY; Xiao L; Strati P; Hagemeister FB; He Y; Chen H; Li Y; Manyam GC; Li Y; Montes-Moreno S; Piris MA; Young KH
Blood Cancer J; 2020 May; 10(5):49. PubMed ID: 32366834
[TBL] [Abstract][Full Text] [Related]
5. Primary mediastinal large B-cell lymphoma.
Savage KJ
Blood; 2022 Sep; 140(9):955-970. PubMed ID: 34496020
[TBL] [Abstract][Full Text] [Related]
6. Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
Chan EHL; Koh LP; Lee J; De Mel S; Jeyasekharan A; Liu X; Tang T; Lim ST; Tao M; Quek R; Farid Bin Harunal Ras M; Lee YS; Diong C; Tan D; Kim SJ; Chee YL; Poon LMM
Cancer Med; 2019 Aug; 8(10):4626-4632. PubMed ID: 31264808
[TBL] [Abstract][Full Text] [Related]
7. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
8. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Rieger M; Österborg A; Pettengell R; White D; Gill D; Walewski J; Kuhnt E; Loeffler M; Pfreundschuh M; Ho AD;
Ann Oncol; 2011 Mar; 22(3):664-670. PubMed ID: 20724576
[TBL] [Abstract][Full Text] [Related]
9. R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Shah NN; Szabo A; Huntington SF; Epperla N; Reddy N; Ganguly S; Vose J; Obiozor C; Faruqi F; Kovach AE; Costa LJ; Xavier AC; Okal R; Kanate AS; Ghosh N; Kharfan-Dabaja MA; Strelec L; Hamadani M; Fenske TS; Calzada O; Cohen JB; Chavez J; Svoboda J
Br J Haematol; 2018 Feb; 180(4):534-544. PubMed ID: 29265182
[TBL] [Abstract][Full Text] [Related]
10. Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics.
Ahmed Z; Afridi SS; Shahid Z; Zamani Z; Rehman S; Aiman W; Khan M; Mir MA; Awan FT; Anwer F; Iftikhar R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e865-e875. PubMed ID: 34330673
[TBL] [Abstract][Full Text] [Related]
11. Primary mediastinal lymphoma: diagnosis and treatment options.
Martelli M; Di Rocco A; Russo E; Perrone S; Foà R
Expert Rev Hematol; 2015 Apr; 8(2):173-86. PubMed ID: 25537750
[TBL] [Abstract][Full Text] [Related]
12. [Progress in treatment of primary mediastinal large B-cell lymphoma].
Chen LW; Li JY; Fan L
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):98-102. PubMed ID: 38527847
[TBL] [Abstract][Full Text] [Related]
13. Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.
Kim SJ; Yoon DH; Kang HJ; Hong JY; Lee HS; Oh SY; Shin HJ; Kong JH; Yi JH; Sakamoto K; Ko YH; Huh J; Lee SS; Takeuchi K; Shin DY; Suh C; Kim WS
BMC Cancer; 2019 Nov; 19(1):1080. PubMed ID: 31707975
[TBL] [Abstract][Full Text] [Related]
14. R-CHOP without radiation in frontline management of primary mediastinal B-cell lymphoma.
Messmer M; Tsai HL; Varadhan R; Swinnen LJ; Jones RJ; Ambinder RF; Shanbhag SP; Borowitz MJ; Wagner-Johnston N
Leuk Lymphoma; 2019 May; 60(5):1261-1265. PubMed ID: 30656983
[TBL] [Abstract][Full Text] [Related]
15. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A
Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734
[TBL] [Abstract][Full Text] [Related]
16. Current and emerging treatment options in primary mediastinal B-cell lymphoma.
Fakhri B; Ai W
Ther Adv Hematol; 2021; 12():20406207211048959. PubMed ID: 34659697
[TBL] [Abstract][Full Text] [Related]
17. Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Fidelity of Diagnosis Using WHO Criteria.
Fairchild A; McCall CM; Oyekunle T; Niedzwiecki D; Champ C; McKinney M; Kelsey CR
Clin Lymphoma Myeloma Leuk; 2021 May; 21(5):e464-e469. PubMed ID: 33487576
[TBL] [Abstract][Full Text] [Related]
18. Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
Abramson JS
Cancer; 2019 Sep; 125(18):3111-3120. PubMed ID: 31287161
[TBL] [Abstract][Full Text] [Related]
19. Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
Pinnix CC; Dabaja B; Ahmed MA; Chuang HH; Costelloe C; Wogan CF; Reed V; Romaguera JE; Neelapu S; Oki Y; Rodriguez MA; Fayad L; Hagemeister FB; Nastoupil L; Turturro F; Fowler N; Fanale MA; Nieto Y; Khouri IF; Ahmed S; Medeiros LJ; Davis RE; Westin J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):113-21. PubMed ID: 25863759
[TBL] [Abstract][Full Text] [Related]
20. The role of pembrolizumab in relapsed/refractory primary mediastinal large B-cell lymphoma.
Tomassetti S; Chen R; Dandapani S
Ther Adv Hematol; 2019; 10():2040620719841591. PubMed ID: 31040936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
